40 results on '"Resteghini C"'
Search Results
2. 224O Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration
3. 708TiP BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment
4. 664P A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era
5. 868P A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts)
6. Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
7. PH-0043: Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients
8. PO-165 Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract
9. PO-115 Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
10. PO-161 Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials
11. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
12. Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area
13. Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma
14. A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma
15. Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer
16. A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer
17. Sinonasal non-glandular cancers relapsing after multimodal treatments
18. RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)
19. Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding
20. Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
21. PD-034: Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer
22. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
23. Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma
24. Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting
25. Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience
26. Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience
27. An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients?
28. Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients
29. RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted?
30. Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area
31. Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer
32. Site of metastatic disease influences adenoid cystic cancer (ACC) patients' outcome
33. Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
34. 2865 Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): A retrospective analysis
35. 2827 Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer
36. PO-113: Activity and Safety of Vinorelbine in Adenoid Cystic Carcinoma: A Single Institution Retrospective Case Series
37. PO-092: Salivary Cytokine Levels and Mucositis in Head and Neck Cancer Patients Treated with Chemoradiotherapy.
38. Healthcare Associated Infections in Head and Neck Carcinoma Patients Treated with Chemotherapy and/or Radiotherapy
39. The Impact of Induction Chemotherapy on Cisplation Dose Intensity During Chemo-Radiotherapy (CTRT) in Oropharyngeal Squamous Cell Cancer (OPC)
40. Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.